Wandashan injection of all pharmaceutical products were suspended business initiative to recall all
Xinhua Beijing on October 18 (Reporter ZHOU Ting-Yu, Xu Jun) 18 reporters from the State Food and Drug Authority was informed that the pharmaceutical factory in Heilongjiang Province Wandashan 17 based on the "management of drugs called" relevant provisions of the initiative to recall their All specifications and product lot number of injections.
In order to eliminate drug safety to ensure that drug safety, the Ministry of Health and State Food and Drug Authority also jointly issued a circular calling for an immediate moratorium on the sale of various parts of the use of Heilongjiang Province for Wandashan marked Pharmaceutical (Heilongjiang Wandashan Pharmaceutical Company Limited Company) of all injections, to do a good job with the work of drug recall. At the same time, all over the Food and Drug administration to supervise the recall enterprises, and pay close attention to the injection of adverse drug reactions.
Oct. 6 this year, the State Food and Drug Administration in Yunnan Province received a report of the Food and Drug Administration, the Yunnan Honghe Prefecture 6 patients with the use of the mark for Wandashan pharmaceutical factory in Heilongjiang Province produced two groups of "Ciwujia injection Solution, "serious adverse reactions, of whom 3 died.
"Ciwujia injection of" serious adverse events occurred, the Ministry of Health and State Food and Drug Administration has asked to suspend sales of pharmaceutical production and use of Wandashan "Ciwujia injection." State Food and Drug Administration, which had been ordered to recall pharmaceutical factory in Heilongjiang Province, has Wandashan listing all the specifications and the lot number "Ciwujia injection."
State Food and Drug Administration said the investigation is still underway.